Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Immunotherapies for neurodegenerative diseases: current status and potential of plant-made biopharmaceuticals.
Influenza vaccination increases anti-JC virus antibody levels during treatment with Natalizumab: Case report.
Rituximab in multiple sclerosis: A retrospective observational study on safety and efficacy.
Immunomodulation of inflammatory leukocyte markers during intravenous immunoglobulin treatment associated with clinical efficacy in chronic inflammatory demyelinating polyradiculoneuropathy.
Fampridine and real-life walking in multiple sclerosis: Low predictive value of clinical test for habitual short-term changes.
Neurodegeneration in multiple sclerosis and neuromyelitis optica.
Acorda Therapeutics announces initiation of AMPYRA® proof-of-concept study in patients with post-stroke deficits
Subgroup and sensitivity analyses of annualized relapse rate over 2 years in the ADVANCE trial of peginterferon beta-1a in patients with relapsing-remitting multiple sclerosis.
Electroencephalography-Derived Sensory and Motor Network Topology in Multiple Sclerosis Fatigue.
Dimethyl fumarate in multiple sclerosis: latest developments, evidence and place in therapy.
Myelitis in systemic lupus erythematosus: clinical characteristics and effect in accrual damage. A single-center experience.
S100A8/A9: From basic science to clinical application.
Similar impact of multiple sclerosis and migraine on sexual function in women : Is the multiple sclerosis impact scale questionnaire useful?
Schwann Cell O-GlcNAc Glycosylation Is Required for Myelin Maintenance and Axon Integrity.
Multiple sclerosis : understanding a complex neurological condition.
Generation of a LacZ reporter transgenic mouse line for the stereological analysis of oligodendrocyte loss in galactosylceramidase deficiency.
Glycyrrhizic acid prevents astrocyte death by neuromyelitis optica-specific IgG via inhibition of C1q binding.
Opportunities and considerations for visualising neuroimaging data on very large displays.
Long-term outcome of changes in cognitive function of young rats after various/different doses of whole brain irradiation.
PDCD1 PD-1.3 polymorphism and allergic bronchial asthma in Russian and Buryat patients.
The relevance of vitamin D receptor gene polymorphisms for vitamin D research in multiple sclerosis.
Antiganglioside, antiganglioside-complex, and antiglycolipid-complex antibodies in immune-mediated neuropathies.
Massage therapy research review.
Siponimod (BAF312) prevents synaptic neurodegeneration in experimental multiple sclerosis.
Erratum to: IFN-gamma signaling in the central nervous system controls the course of experimental autoimmune encephalomyelitis independently of the localization and composition of inflammatory foci.
Pages
« first
‹ previous
…
765
766
767
768
769
770
771
772
773
…
next ›
last »